ALB vs CELUW · rev $1.74B vs rev $54.2M
Albemarle Corp (ALB) versus Celularity Inc (CELUW) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
Celularity Inc (CELUW) common stock listed on US.
Latest reported ALB revenue for 2026-06-30 was $1.74B. Net income was $480.0M. Revenue was up 22.0% from 2026-03-31 to 2026-06-30. ALB currently screens at market cap $8.00B.
Latest reported CELUW revenue for 2024-12-31 was $54.2M. Net income was -$57.9M. Revenue was up 138.1% from 2023-12-31 to 2024-12-31. CELUW currently screens at market cap $0.
ALB currently screens at market cap $8.00B. CELUW currently screens at market cap $0.
Not investment advice. Open the ALB and CELUW stock pages for the full models.
Not investment advice.